Please assess the completion status of the following clinical trial:

Trial Title: Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of non-small-cell carcinoma of the lung~* Patients with locally advanced disease or metastatic disease, candidates to surgery after evaluation by oncologist and thoracic surgeon~* Tumour with possibility of curative surgery~* At least one uni-dimensionally measurable lesion~* Adequate pulmonary function to perform the planned surgical resection~Exclusion Criteria:~* Active infection (at the investigator's discretion)~* Pregnancy or breast-feeding~* Serious concomitant illness at the investigator's discretion~* Previous diagnosis of malignant disease~* They have received treatment during the last 30 days with a drug, other than the study drug, that has not received regulatory approval for any indication at the time of their entry in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).